OSMOTICA PHARMACEUTICALS PLC - SHS (RVLPQ)

CUSIP: G6S41R101

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / SHS
Total 13F shares
25,178,425
Share change
+44,716
Total reported value
$28,704,225
Put/Call ratio
0.23%
Price per share
$1.14
Number of holders
40
Value change
+$51,334
Number of buys
10
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP G6S41R101?
CUSIP G6S41R101 identifies RVLPQ - OSMOTICA PHARMACEUTICALS PLC - SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OSMOTICA PHARMACEUTICALS PLC - SHS (RVLPQ) as of Q1 2023

As of 31 Mar 2023, OSMOTICA PHARMACEUTICALS PLC - SHS (RVLPQ) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,178,425 shares. The largest 10 holders included Athyrium Capital Management, LP, Rovida Advisors Inc., ArrowMark Colorado Holdings LLC, AIGH Capital Management LLC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, SCOGGIN MANAGEMENT LP, Worth Venture Partners, LLC, GEODE CAPITAL MANAGEMENT, LLC, and UBS OCONNOR LLC. This page lists 40 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.